Related Experiment Video
Updated: May 1, 2026
05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.9K
Integrative knowledge management to enhance pharmaceutical R&D
Maria Marti-Solano1, Ewan Birney2, Antoine Bril3
1IMIM and Universitat Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain.
Nature Reviews. Drug Discovery
|April 2, 2014
Summary
Information technology is crucial for pharmaceutical research and development (R&D). Advances require overcoming data sharing, integration, and analysis challenges across the R&D lifecycle.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Computational Biology
Background:
- Information technology plays a vital role in modern pharmaceutical research and development (R&D).
- Current R&D processes generate vast and diverse datasets.
- Existing challenges hinder the full potential of these technologies.
Purpose of the Study:
- To highlight the critical role of information technologies in pharmaceutical R&D.
- To identify key challenges impeding the effectiveness of these technologies.
- To emphasize the need for improved data handling in pharmaceutical innovation.
Main Methods:
- Review of current information technology applications in pharmaceutical R&D.
- Analysis of data-related challenges in drug discovery and development.
- Identification of barriers to data sharing, integration, and joint analysis.
Main Results:
- Information technologies are indispensable tools in pharmaceutical R&D.
- Significant advancements are constrained by difficulties in data sharing.
- Integration and collaborative analysis of R&D data remain substantial hurdles.
Conclusions:
- Overcoming data challenges is essential for maximizing the impact of information technology in pharmaceutical R&D.
- Enhanced data strategies are necessary to drive innovation.
- Future progress depends on collaborative approaches to data management.
Related Concept Videos
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
547
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
547
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
01:26Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
358
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
358
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121